These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3552428)

  • 1. Management of chronic ciclosporin-related nephrotoxicity.
    Kahan BD; Flechner SM; Lorber MJ; Van Buren CT
    Contrib Nephrol; 1986; 51():96-101. PubMed ID: 3552428
    [No Abstract]   [Full Text] [Related]  

  • 2. [Report of experiences on the use of cyclosporin A].
    Konert J; Eismann R; Heinrichs HJ; Langkopf B
    Z Gesamte Inn Med; 1988 Sep; 43(17):477-9. PubMed ID: 3070973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple low-dose immunosuppression with cessation of steroids in pediatric renal transplantation.
    Walker RG; d'Apice AJ; Powell HR; Francis DM; Kincaid-Smith P
    Transplant Proc; 1988 Feb; 20(1):7-10. PubMed ID: 3278465
    [No Abstract]   [Full Text] [Related]  

  • 4. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
    Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppression with a combination of cyclosporin, azathioprine, and prednisolone may be unsafe.
    Salaman JR; Griffin PJ
    Lancet; 1985 Nov; 2(8463):1066-7. PubMed ID: 2865541
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine.
    Schareck WD; Hopt UT; Müller GH; Greger B; Risler T; Bockhorn H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 9. Triple therapy in cadaver renal transplantation.
    Jones RM; Murie JA; Allen RD; Ting A; Morris PJ
    Br J Surg; 1988 Jan; 75(1):4-8. PubMed ID: 3276369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciclosporin in acute and chronic renal graft rejection.
    Vangelista A; Frascà GM; Buscaroli A; Borgnino LC; Bonomini V
    Contrib Nephrol; 1986; 51():45-50. PubMed ID: 3552419
    [No Abstract]   [Full Text] [Related]  

  • 11. Experience with cyclosporine and prednisone as immunosuppressants in 36 renal transplants.
    Kovithavongs T; Boake R; Lakey WH; Ulan RA; Dossetor JB
    Transplant Proc; 1984 Aug; 16(4):1083-5. PubMed ID: 6380055
    [No Abstract]   [Full Text] [Related]  

  • 12. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
    Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
    [No Abstract]   [Full Text] [Related]  

  • 13. [Our experience with the monitored cyclosporin A treatment of kidney transplant patients].
    Beleva B; Kurtev I; Stefanov G
    Khirurgiia (Sofiia); 1987; 40(3):66-70. PubMed ID: 3306122
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical results of ciclosporin-prednisone therapy in renal transplantation.
    Kahan BD; Kerman RH; Flechner SM; Lorber MI; Van Buren CT
    Contrib Nephrol; 1986; 51():55-60. PubMed ID: 3105957
    [No Abstract]   [Full Text] [Related]  

  • 15. The problems associated with conversion from azathioprine and prednisolone to cyclosporine.
    Chapman JR; Taylor HM; Thompson JF; Wood RF; Morris PJ
    Uremia Invest; 1985-1986; 9(1):19-25. PubMed ID: 3915162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring the response to anti-rejection therapy with serum neopterin.
    Smillie AE; Rigby RJ; Petrie JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1869-70. PubMed ID: 2652608
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and experimental studies with cyclosporine in renal transplantation.
    Kahan BD; van Buren CT; Flechner SM; Jarowenko M; Yasumura T; Rogers AJ; Yoshimura N; LeGrue S; Drath D; Kerman RH
    Surgery; 1985 Feb; 97(2):125-40. PubMed ID: 3881837
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of low-dose cyclosporine A in combination with azathioprine and steroids in renal transplantation.
    Slapak M; Geoghegan T; Digard N; Ahmed K; Sharman VL; Crockett R
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):41-5. PubMed ID: 3551255
    [No Abstract]   [Full Text] [Related]  

  • 19. The case against conversion to azathioprine in cyclosporine-treated renal recipients.
    Flechner SM; Lorber M; Van Buren C; Kerman R; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667
    [No Abstract]   [Full Text] [Related]  

  • 20. Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone.
    O'Connell P; d'Apice A; Walker R; Francis D; Kincaid-Smith P
    Transplant Proc; 1988 Feb; 20(1):11-3. PubMed ID: 3278450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.